Theme

Oxf Instruments

OXIGTechnology
1,842.00GBX
1.77%
Market Cap
1.05B
Volume
195.96k
151% of avg
P/E Ratio
16.02
EPS (TTM)
114.98
Beta
0.95
Day Range
1,810.00p - 1,858.00p
52 Week Range
1,470.00p1,842.00p2,237.50p
1,842.00p

Upcoming Events

October to November 2025
Expected half-year results announcement for 2025/26
High Impact Event
Q3 2026
Expected completion of the sale
High Impact Event
31 July 2028
Vesting of long-term incentive awards
OXIG
NEUTRAL

Oxford Instruments Announces Director/PDMR Shareholding

The scientific instruments company has announced changes to its directors' and PDMRs' shareholdings.

OXIG
NEUTRAL

Oxford Instruments Announces Change in Major Shareholding

The technology company has announced a change in major shareholding, with Aberdeen Group plc now holding over 5% of the voting rights.

OXIG
NEUTRAL

Oxford Instruments Announces Change in Shareholding

The technology company has announced a change in its major shareholding, with Aberdeen Group plc reducing its stake below 5%.

OXIG
NEUTRAL

Oxford Instruments Announces Major Shareholder Disclosure

The scientific instruments maker has announced a change in major shareholder holdings.

OXIG
NEUTRAL

Oxford Instruments Director Acquires Shares

The retailer has announced a director has acquired shares in the company.

OXIG
NEUTRAL

Oxford Instruments Announces Director Departure

The scientific technology company announces the departure of a non-executive director from its board.

OXIG
NEUTRAL

Oxford Instruments Director Acquires Shares

The CEO of the scientific instruments company has acquired shares as part of his deferred bonus scheme.

OXIG
NEUTRAL

Oxford Instruments Director Acquires Shares

The CEO of the scientific instruments company has acquired a small number of shares through the firm's employee share plan.

OXIG
NEUTRAL

Oxford Instruments Announces Major Shareholder Disclosure

The scientific technology company discloses a change in major shareholder holdings.

OXIG
NEUTRAL

Oxford Instruments Announces Director Share Purchase

The prominent scientific technology company has announced a director has acquired additional ordinary shares.